Molecular characterization of dipeptidyl peptidase activity in serum
Open Access
- 1 September 2000
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 267 (17), 5608-5613
- https://doi.org/10.1046/j.1432-1327.2000.01634.x
Abstract
Dipeptidyl peptidase IV (DPPIV, EC 3.4.14.5) is a serine type protease with an important modulatory activity on a number of chemokines, neuropeptides and peptide hormones. It is also known as CD26 or adenosine deaminase (ADA; EC 3.5.4.4) binding protein. DPPIV has been demonstrated on the plasmamembranes of T cells and activated natural killer or B cells as well as on a number of endothelial and differentiated epithelial cells. A soluble form of CD26/DPPIV has been described in serum. Over the past few years, several related enzymes with similar dipeptidyl peptidase activity have been discovered, raising questions on the molecular origin(s) of serum dipeptidyl peptidase activity. Among them attractin, the human orthologue of the mouse mahogany protein, was postulated to be responsible for the majority of the DPPIV-like activity in serum. Using ADA-affinity chromatography, it is shown here that 95% of the serum dipeptidyl peptidase activity is associated with a protein with ADA-binding properties. The natural protein was purified in milligram quantities, allowing molecular characterization (N-terminal sequence, glycosylation type, CD-spectrum, pH and thermal stability) and comparison with CD26/DPPIV from other sources. The purified serum enzyme was confirmed as CD26.Keywords
This publication has 48 references indexed in Scilit:
- The Adenosine Deaminase-Binding Region Is Distinct from Major Anti-CD26 mAb Epitopes on the Human Dipeptidyl Peptidase IV(CD26) MoleculeCellular Immunology, 1999
- Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated CleavageThe Journal of Experimental Medicine, 1997
- A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasmaBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1997
- Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IVNature Biotechnology, 1997
- Dipeptidyl‐Peptidase IV‐β, a Novel form of Cell‐Surface‐Expressed Protein with Dipeptidyl‐Peptidase IV ActivityEuropean Journal of Biochemistry, 1996
- Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serumEuropean Journal of Biochemistry, 1993
- A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.The Journal of Experimental Medicine, 1993
- Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- N-Terminal Amino-Acid Sequence of Pig Kidney Dipeptidyl Peptidase IV Solubilized by AutolysisBiological Chemistry Hoppe-Seyler, 1991
- Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma.JCI Insight, 1989